Skip to main content
. 2021 Nov 25;12:759474. doi: 10.3389/fimmu.2021.759474

Figure 3.

Figure 3

Immunization with recombinant Tp0136 or Tp0663 protein attenuated lesion development. (A) Lesion diameters were monitored over 21 days in the control, Tp0136-immunized or Tp0663-immunized animals following T. pallidum challenge. (B) Indurated lesions from eight locations on the backs of the rabbits were taken 21 days post-intradermal challenge with T. pallidum (Nichols strain).